114542 ⎘
with NAD or NADP as acceptor (1.15.1) Superoxide dismutase (1.15.1.1)
Biomarkers for Long COVID
#2COMPOSITION COMPRISING SUPEROXIDE DISMUTASE AND/OR BACILLUS STRAIN SPORES, AND USE THEREOF FOR IMPROVING ORAL HEALTH
#3CAVIAR POLYPEPTIDES
#4PREPARATION METHOD FOR CORN SUPEROXIDE DISMUTASE
#5ADENO-ASSOCIATED VIRUS (AAV) DIRECTED ANTIOXIDATIVE GENE THERAPY FOR THE PREVENTION, AMELIORATION, AND/OR TREATMENT OF HEARING LOSS
#6BACTERIAL SUPEROXIDE DISMUTASES
#7TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT
#8TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT
#9TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT
#10BACILLUS SPECIES STRAIN EXPRESSING SUPEROXIDE DISMUTASE, BACILLUS SPECIES STRAIN SPORE AND/OR SUPEROXIDE DISMUTASE, AND USE THEREOF FOR PREVENTING OR TREATING OF FIBROTIC DISEASE
#11SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING DIABETIC RETINOPATHY OR UVEITIS
#12THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES
#13ADENO-ASSOCIATED VIRUS GENE THERAPY PRODUCTS AND METHODS
#14SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING MUCOSITIS
#15SALT TOLERANT PLANTS
#16TARGETING NANOENZYME FOR MITIGATING CHEMOTHERAPY-INDUCED CARDIOTOXICITY, PREPARATION METHOD
#17DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS FOR RNA INTERFERENCE AND METHODS RELATING THERETO
#18SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING MACULAR DEGENERATION
#19NUCLEOTIDE ANALOGUES, AND PREPARATION AND APPLICATION THEREOF
#20SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING DRY EYE SYNDROME
#21TOPICAL THERAPEUTIC FORMULATIONS
#22AN EDIBLE PRODUCT, FROM CULTIVATED CELLS, WITH AN ENHANCED MEAT-LIKE FLAVOR AND PRODUCTION METHOD THEREOF
#23ASSOCIATION OF A VEGETAL ACTIVE EXTRACT CONTAINING SUPEROXIDE DISMUTASE (SOD) AND A FENUGREEK EXTRACT AND USES THEREOF
#24AAV VECTORS ENCODING SOD1-TARGETING ARTIFICIAL MIRNAS (AMI-RNA)
#25METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#26PLASMONIC METAL-COLLAGEN HYBRID NANOPARTICLES FOR PROTEIN DELIVERY AND METHOD OF PREPARATION THEREOF
#27OLIGONUCLEOTIDE-BASED DELIVERY VEHICLE FOR OLIGONUCLEOTIDES AGENTS AND METHODS OF USE THEREOF
#28ARTIFICIAL BLOOD SUBSTITUTES
#29METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY
#30COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS
#31PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#32Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides
#33USE OF SUPEROXIDE DISMUTASE FOR THE TREATMENT AND/OR PREVENTION OF ALLERGIC ASTHMA
#34MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS
#35TOPICAL THERAPEUTIC FORMULATIONS
#36SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS AND METHODS OF USE
#37LYMPHATIC DELIVERY OF NANOPARTICLES TO TREAT NEURODEGENERATIVE, NEUROLOGICAL, AND EYE CONDITIONS
#38Products and Methods for Treatment of Amyotrophic Lateral Sclerosis
#39COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#40TREATMENT FOR SOD1 ASSOCIATED DISEASE
#41MODULATORY POLYNUCLEOTIDES
#42DEGRADATION OF RNA BY THE LYSOSOMAL PATHWAY
#43TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#44MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME
#45MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACIDS, FATTY ALCOHOLS, AND CULTURED PROTEIN FROM C1 SUBSTRATES
#46BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE
#47ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS
#48SUPEROXIDE DISMUTASE 1 VARIANT AND METHOD FOR PRODUCING GLUTATHIONE OR DERIVATIVE THEREOF, USING SAME
#49Tethering Cysteine Residues Using Cyclic Disulfides
#50METHODS AND COMPOSITIONS FOR INHIBITING OXIDATIVE STRESS
#51Products and Methods for Treatment of Amyotrophic Lateral Sclerosis
#52PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DISORDER ASSOCIATED WITH ADMINISTRATION OF ANTICANCER AGENT
#53METHOD AND SYSTEM FOR SIMULTANEOUSLY EXTRACTING POLYSACCHARIDES, POLYPHENOLS, SOD AND VC OF ROSA ROXBURGHII TRATT FROM ROSA ROXBURGHII TRATT POMACE
#54ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE
#55TREATEMENT OF PATHOGEN INFECTIONS FORMULATIONS AND METHODS FOR USE
#56SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS
#57SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASES
#58TREATEMENT OF PATHOGEN INFECTIONS FORMULATIONS AND METHODS FOR USE
#59METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION COMPRISING ENZYMES SUCH AS MURAMIDASE
#60BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
#61RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#62COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING, AS ACTIVE INGREDIENT STEM CELLS OVEREXPRESSING SOD3
#63Topical therapeutic formulations
#64Chemically Defined Serum Albumin Substitutes
#65HUMAN ORAL MUCOSA STEM CELL SECRETOME
#66METHODS OF MODULATING GASTROINTESTINAL METABOLITES
#67Enzymatic Preservation of Probiotics in Animal Feed
#68Enzymatic Feed Preservation
#69TEST METHOD FOR MILD COGNITIVE IMPAIRMENT, TEST REAGENT FOR MILD COGNITIVE IMPAIRMENT, AND METHOD FOR SCREENING THERAPEUTIC CANDIDATE SUBSTANCES FOR MILD COGNITIVE IMPAIRMENT
#70Bacterial Superoxide Dismutases
#71COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH AAV-MIR-SOD1
#72Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#73ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING
#74SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS
#75COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION
#76Joint Health Composition and Use Thereof in Healthy Mammals
#77BICOMPATIBLE PEPTIDEBIOCOMPATIBLE PEPTIDES FOR INHIBITION OF AGGREGATION OF B-AMYLOID PROTEIN
#78COMPOSITIONS AND METHODS FOR BASE SPECIFIC MITOCHONDRIAL GENE EDITING
#79COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT
#80TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#81Topical therapeutic formulations
#82IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS
#83BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
#84Preparation method of high-stability superoxide dismutase with transmembrane capability
#85Baculovirus Of Recombinant Superoxide Dismutase Gene, Preparation And Application Thereof
#86Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases
#87COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL INFECTION DISEASE, CONTAINING ACTIVE OXYGEN PRODUCTION INHIBITOR AND ACTIVE OXYGEN SCAVENGER COMPLEX AS ACTIVE INGREDIENTS
#88TREATMENT FOR SOD1 ASSOCIATED DISEASE
#89Methods of treating spinal cord injury
#90Paramyxovirus virus-like particles as protein delivery vehicles
#91REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
#92THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES
#93REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
#94SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS
#95USE OF A MANGANESE SUPEROXIDE DISMUTASE WITH HIGH STABILITY IN THE PREVENTION OR TREATMENT OF CEREBRAL STROKE
#96PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#97Biomarkers useful in the treatment of subjects having diseases of the eye
#98Tethering cysteine residues using cyclic disulfides
#99Modulatory polynucleotides
#100SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE
#101COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS
#102Skin Care Formulation for Treatment of Cellulite
#103GENE THERAPY FOR OXIDATIVE STRESS
#104SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS
#105RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#106Means and method for producing and purifying viral vectors
#107INDUSTRIAL APPLICATIONS OF PLANT CELL EXTRACTS COMPRISING SOD ENZYMES OF EXTREMOPHILIC MICRO-ORGANISMS
#108Methods and compositions for inhibiting oxidative stress
#109COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION
#110RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#111COMPOSITIONS AND METHODS FOR CELL CULTURE
#112Radioprotection, Radiomitigation and Radiorecovery
#113Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#114METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#115Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis
#116Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier
#117RIBAVIRIN PERFLUBRON EMULSION COMPOSITION FOR TREATING VIRAL DISEASES
#118Transdermal peptide with nuclear localization ability and use thereof
#119Veterinary Composition Comprising Superoxide Dismutase and at Least One Hydrolysate of Proteins Rich in Bioassimilable Peptides
#120Super-oxide dismutase soluble fiber compositions
#121Acute Respiratory Distress Syndrome Therapeutic Agent
#122Compositions for modulating SOD-1 expression
#123TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#124Tethering cysteine residues using cyclic disulfides
#125Lipid supplements for reducing nerve action potentials
#126Modulatory polynucleotides
#127Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#128HUMAN ORAL MUCOSA STEM CELL SECRETOME
#129SUPEROXIDE DISMUTASE GENE AND ITS CODING PROTEIN
#130Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#131Topical therapeutic formulations
#132Compositions for modulating SOD-1 expression
#133RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#134METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA
#135Transdermal peptide with nuclear localization ability and use thereof
#136Bioresponsive particles
#137GF423 strain, and composition for providing antioxidant and anti-inflammatory activities or preventing or treating hyperlipidemia, including polypeptide produced by the same
#138Paramyxovirus virus-like particles as protein delivery vehicles
#139Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
#140RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#141RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#142PROOXIDANT CANCER CHEMO-SUPPRESSORS AND CHEMO-PROTECTORS AND METHODS OF USE RELATED THERETO
#143COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1
#144USE OF EARTHWORM PROTEIN FOR PREPARING PHARMACEUTICAL COMPOSITION FOR PROTECTION OF BRAIN NEURONS
#145Compositions for cryopreservation and methods of use thereof
#146Materials and methods for detection and quantification of β-N-methylamino-L-alanine
#147Products and methods for treatment of familial amyotrophic lateral sclerosis
#148Combined treatment for nerve injuries
#149Method of Preparation of SOD Hydrolysates Powder
#150Oral lipid supplements for treating pain and fibromyalgia
#151Microparticles for cell disruption and/or biomolecule recovery
#152Method for genetic treatment using the AAV-XBP1s/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosis
#153Isolated polypeptide and compositions comprising same
#154BACTERIA ENGINEERED TO TREAT METABOLIC DISEASES
#155DIETARY SUPPLEMENTS AND FORMULATIONS
#156DIETARY SUPPLEMENTS AND FORMULATIONS
#157ANIMAL FEED BOLUS AND METHODS FOR MANUFACTURING THE SAME
#158Composition for preventing or treating inflammatory diseases, containing, as active ingredient, stem cells overexpressing SOD3
#159Acute Respiratory Distress Syndrome Therapeutic Agent
#160Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#161Recombinant high-stability superoxide dismutase and application thereof
#162Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#163Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier
#164Tethering cysteine residues using cyclic disulfides
#165Tethering cysteine residues using cyclic disulfides
#166Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
#167Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
#168Method for obtaining a biomass of a microalga of the species enriched in superoxide dismutase (SOD)
#169SYNERGISTIC GLYCOCALYX TREATMENT COMPOSITIONS AND METHODS
#170RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#171Method for Obtaining a Superoxide Dismutase (SOD)-Concentrated Protein Extract
#172Biomarkers useful in the treatment of subjects having diseases of the eye
#173Chewable lipid supplements for treating pain and fibromyalgia
#174Modulatory polynucleotides
#175Compositions and methods for the treatment of photoaging and other conditions
#176COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN PRODUCTION
#177Paramyxovirus virus-like particles as protein delivery vehicles
#178COMPOSITIONS AND METHODS FOR CELL CULTURE
#179Recombinant AAV vectors useful for reducing immunity against transgene products
#180Treatment of amyotrophic lateral sclerosis
#181Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#182RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#183Bi-layer dual release probiotic tablets
#184Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#185Compositions for modulating SOD-1 expression
#186Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
#187Dietary supplements and formulations
#188COMPOSITION INVOLVED IN REGULATING ENERGY CYCLE, INFLAMMATION AND INSULIN RESISTANCE DYSFUNCTIONS, AND USE THEREOF PARTICULARLY IN CARDIOMETABOLIC DISEASES
#189TERMITE SUPEROXIDE DISMUTASES AND GLUTATHIONE PEROXIDASES FOR BIOMASS CONVERSION
#190Tethering cysteine residues using cyclic disulfides
#191Augmentation of oncology immunotherapies by pterostilbene containing compositions
#192Synergistic glycocalyx treatment compositions and methods
#193Methods and compositions for inhibiting oxidative stress
#194Manganese superoxide dismutase variants and uses thereof
#195HEXAPEPTIDE AND USES THEREOF
#196COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC STEATOSIS AND STEATOHEPATITIS
#197Microparticles for cell disruption and/or biomolecule recovery
#198Adsorbent composition and use thereof
#199Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
#200Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#201Methods and systems for predicting misfolded protein epitopes
#202Topical therapeutic formulations
#203COMPOSITION FOR STABILIZING EC-SOD AND METHOD OF STABILIZING EC-SOD USING THE SAME
#204Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
#205Topical therapeutic formulations
#206Cosmetic composition comprising a collagen protecting or enhancing agent and particles comprising silica and titanium dioxide topical compositions
#207METHOD OF IMPROVING HEMATOLOGICAL PARAMETERS AND BRAIN DYSFUNCTION WITH GANODERMA TSUGAE EXTRACT
#208HUMAN-DERIVED MUTANTS OF THE dSOD1 GENE IN DROSOPHILA AND METHODS OF MAKING AND USING
#209Methods of treating spinal cord injury
#210Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders
#211CYLINDRINS AS ETIOLOGIC AGENTS OF AMYLOID DISEASES
#212Tethering cysteine residues using cyclic disulfides
#213Antisense modulation of superoxide dismutase 1, soluble expression
#214Topical therapeutic formulations
#215MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#216Use of EC-SOD for treating angiogenesis-mediated eye diseases
#217Use of EC-SOD and method for preparing thereof
#218Compositions and methods for enhancing penetration of biologically active substances into tissues or organs
#219Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
#220Nucleic acid encoding superoxide dismutase variants and methods of use thereof
#221Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#222Metal abstraction peptide with superoxide dismutase activity
#223Blood substitutes and uses thereof
#224Topical therapeutic formulations
#225Compositions and Methods for the Treatment of Lung Inflammation
#226METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE
#227METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA
#228Methods for slowing familial ALS disease progression
#229NOVEL EXPRESSION VECTOR
#230Cross-Linking of Superoxide Dismutase Monomers
#231Superoxide dismutase variants and methods of use thereof
#232NOVEL USE OF EC-SOD AND METHOD FOR PREPARING THEREOF
#233Antisense modulation of superoxide dismutase 1, soluble expression
#234Mutant human superoxide dismutase 1 variants
#235METHOD FOR TREATING AND PREVENTING RADIATION DAMAGE USING GENETICALLY MODIFIED MESENCHYMAL STEM CELLS
#236Allele-specific RNA interference
#237Smoking cessation with body weight maintenance and nutritional supplement
#238Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
#239Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#240EC SOD and use thereof
#241METHODS AND SYSTEMS FOR PREDICTING MISFOLDED PROTEIN EPITOPES
#242METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION
#243METHODS AND AGENTS FOR REDUCING OXIDATIVE STRESS
#244Use of a Mixture of Superoxide Dismutase and Catalase for Treating Inflammatory Skin Lesions
#245Methods and compositions for treating gain-of-function disorders using RNA interference
#246Method for inhibiting reperfusion injury in the brain
#247SYSTEM, DEVICES, AND METHODS FOR IONTOPHORETIC DELIVERY OF COMPOSITIONS INCLUDING ANTIOXIDANTS ENCAPSULATED IN LIPOSOMES
#248Extracellular superoxide dismutase (EC-SOD) gene delivery to prevent oxidative injury
#249Nutritional formula for athletes' recovery
#250EC SOD and cell transducing EC SOD and use thereof
#251Compositions and methods for enhancing discriminatory RNA interference
#252Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#253Skin treatment preparation
#254Lecithinized superoxide dismutase composition and a process for its production
#255Methods for slowing familial ALS disease progression
#256Antisense modulation of superoxide dismutase 1, soluble expression
#257Methods of delivering therapeutics to the brain
#258Rice conferring resistance to environmental stress by targeting MnSOD to the chloroplast
#259Antisense modulation of superoxide dismutase 1, soluble expression
#260Adeno-associated virus-delivered ribozyme compositions and methods of use
#261Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)
#262Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
#263Allele-specific RNA interference
#264Recombinant BCG strains with attenuated immunosuppressive properties
#265Method and composition for inhibiting reperfusion injury in the brain
#266Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD)
#267Methods and compositions for treating gain-of-function disorders using RNA interference
#268Methods of treating xerostomia and xerophthalmia
#269Antisense modulation of superoxide dismutase 1, soluble expression
#270Selenium-containing nano HOF, antioxidant nanozyme, preparation method and application thereof